OBJECTIVE: The impact of increased fructose consumption on carbohydrate metabolism is a topic of current interest, but determination of serum level has been hindered due to low concentration and interference from serum glucose. We are reporting a method for the quantification of glucose and fructose in clinical samples using gas chromatography/mass spectrometry (GC/MS). The accuracy and precision of GC/MS and an enzymatic assay were compared. DESIGN AND METHODS: Mass spectrometry fragmentation patterns of methyloxime peracetate derivatized aldose and ketose were determined. Unique fragments for glucose and fructose were used for quantitative analysis using isotope labeled recovery standards. RESULTS: Methyloxime peracetate derivatives of glucose and fructose showed characteristic loss of acetate (M-60) or ketene (M-42) under chemical ionization (CI). Under electron impact (EI) ionization, a unique C1-C2 fragment of glucose was formed, while a C1-C3 fragment was formed from keto-hexoses. These unique fragments were used in the quantitative assay of glucose and fructose in clinical samples. In clinical samples, the GC/MS assay has a lower limit of detection than that of the enzymatic assay. In plasma samples from patients evaluated for diabetes the average serum glucose and fructose were 6.19+/-2.72 mM and 46+/- 25.22 microM. Fructose concentrations in many of these samples were below the limit of detection of the enzymatic method. CONCLUSION: Derivatization of aldose and ketose monosaccharides to their respective O-methyloxime acetates for GC/MS analysis is a facile method for determination of serum/plasma glucose and fructose samples. Copyright 2009 The Canadian Society of Clinical Chemists. All rights reserved.
OBJECTIVE: The impact of increased fructose consumption on carbohydrate metabolism is a topic of current interest, but determination of serum level has been hindered due to low concentration and interference from serum glucose. We are reporting a method for the quantification of glucose and fructose in clinical samples using gas chromatography/mass spectrometry (GC/MS). The accuracy and precision of GC/MS and an enzymatic assay were compared. DESIGN AND METHODS: Mass spectrometry fragmentation patterns of methyloxime peracetate derivatized aldose and ketose were determined. Unique fragments for glucose and fructose were used for quantitative analysis using isotope labeled recovery standards. RESULTS:Methyloxime peracetate derivatives of glucose and fructose showed characteristic loss of acetate (M-60) or ketene (M-42) under chemical ionization (CI). Under electron impact (EI) ionization, a unique C1-C2 fragment of glucose was formed, while a C1-C3 fragment was formed from keto-hexoses. These unique fragments were used in the quantitative assay of glucose and fructose in clinical samples. In clinical samples, the GC/MS assay has a lower limit of detection than that of the enzymatic assay. In plasma samples from patients evaluated for diabetes the average serum glucose and fructose were 6.19+/-2.72 mM and 46+/- 25.22 microM. Fructose concentrations in many of these samples were below the limit of detection of the enzymatic method. CONCLUSION: Derivatization of aldose and ketose monosaccharides to their respective O-methyloxime acetates for GC/MS analysis is a facile method for determination of serum/plasma glucose and fructose samples. Copyright 2009 The Canadian Society of Clinical Chemists. All rights reserved.
Authors: Wen C Aw; Samuel G Towarnicki; Richard G Melvin; Neil A Youngson; Michael R Garvin; Yifang Hu; Shaun Nielsen; Torsten Thomas; Russell Pickford; Sonia Bustamante; Antón Vila-Sanjurjo; Gordon K Smyth; J William O Ballard Journal: PLoS Genet Date: 2018-11-06 Impact factor: 5.917
Authors: Yang An; Vijay R Varma; Sudhir Varma; Ramon Casanova; Eric Dammer; Olga Pletnikova; Chee W Chia; Josephine M Egan; Luigi Ferrucci; Juan Troncoso; Allan I Levey; James Lah; Nicholas T Seyfried; Cristina Legido-Quigley; Richard O'Brien; Madhav Thambisetty Journal: Alzheimers Dement Date: 2017-10-19 Impact factor: 21.566
Authors: S Lablanche; C Cottet-Rousselle; F Lamarche; P-Y Benhamou; S Halimi; X Leverve; E Fontaine Journal: Cell Death Dis Date: 2011-03-24 Impact factor: 8.469
Authors: Vijayalakshmi Varma; László G Boros; Greg T Nolen; Ching-Wei Chang; Martin Wabitsch; Richard D Beger; Jim Kaput Journal: Metabolomics Date: 2014-08-03 Impact factor: 4.290
Authors: James P Garnett; Daniela Braun; Alex J McCarthy; Matthew R Farrant; Emma H Baker; Jodi A Lindsay; Deborah L Baines Journal: Cell Mol Life Sci Date: 2014-05-09 Impact factor: 9.261